BioPharma Predicting Pre-Eclampsia Pre-eclampsia, a condition affecting pregnant women, remains poorly understood despite affecting up to one in ten pregnancies worldwide. The condition kills 70,000 mothers and half a million babies globally each year. If diagnosed...
BioPharma Predicting dementia nine years before symptoms Researchers at Queen Mary’s Centre of Preventive Neurology have developed a new method for predicting dementia with over 80% accuracy and up to nine years before a diagnosis. The new method provides a more...
BioPharma Diagnosing type 1 diabetes using insulin neoepitopes Diabetes is one of the most common chronic diseases in Britain – and is getting ever more prevalent. Although less than one in ten diabetes patients have type 1 diabetes, it is much more common among...
BioPharma A Rapid PCR Test for Early Cancer Diagnosis A novel qPCR-based diagnostic test for detecting oral cancer risk and predicting patient prognosis. qMIDSv2 is low cost, rapid, and minimally invasive. It requires only 1mm3 of biopsy material and is applicable to...
BioPharma Megakaryocytes and circulating tumour cells as a cancer prognostic marker Prostate cancer is the most common cancer in Western men and the second most frequent cause of cancer-related death. Most prostate cancer deaths are caused by metastases, which are...
